Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
The European Journal of Health Economics
Published in: The European Journal of Health Economics 5/2010

01-10-2010 | Original Paper

Expenditures of the German statutory health insurance system for patients suffering from acute coronary syndrome and treated with percutaneous coronary intervention

Authors: Heiko Friedel, Anne Delges, Johannes Clouth, Dana T. Trautvetter

Published in: The European Journal of Health Economics | Issue 5/2010

Login to get access

Abstract

Patients with acute coronary syndrome (ACS) are in need of cost-intensive treatment involving different aspects of the German Health System. Percutaneous coronary intervention (PCI) is the treatment of choice for a large proportion of cases. In the present study, an analysis of the cost impact of ACS with focus on PCI therapy was conducted across-the-board for the German Health System. Results indicated that 85% of all costs arising from treatment of ACS with a trial of PCI are due to in-patient care. Projection of results onto the entire insurant collective of the statutory health system estimated a total of €954,995,603—a proportional 0.7% of all expenditure by statutory health insurances in 2005.
Literature
1.
Möllmann, H., Elsässer, A., Nef, H.M., et al.: Akutes Koronarsyndrom mit und ohne ST-Elevation. Herz 31, 820–826 (2006)CrossRef
2.
Hamm, C.W.: Leitlinien: Akutes Koronarsyndrom (ACS) Teil 1: ACS ohne persistierende ST-Hebung. Z. Kardiol. 93, 72–90 (2004)CrossRef
3.
Hamm, C.W.: Leitlinien: Akutes Koronarsyndrom (ACS) Teil 2: Akutes Koronarsyndrom mit ST-Hebung. Z. Kardiol. 93, 324–341 (2004)CrossRef
4.
German Census Bureau: Ergebnisse der Todesursachenstatistik für Deutschland ausführliche vierstellige ICD10-Klassifikation. Wiesbaden (2007)
5.
Silber, S., Albertsson, A., Avilés, F.F.: Guidelines for percutaneous coronary interventions. Eur. Heart J. 26, 804–847 (2005)CrossRef
6.
Bassand, J.P., Hamm, C.W., Ardissino, D., et al.: Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur. Heart J. 28, 1598–1660 (2007)CrossRef
7.
Murray, C.J.L., Lopez, Z.D.: Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 349(9064), 1498–1504 (1997)CrossRef
8.
Van de Werf, F., Bax, J., Betriu, A., et al.: Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Eur. Heart J. 29, 2909–2945 (2008)CrossRef
9.
Zhang, Z., Spertus, J.A., Mahoney, E.M., et al.: The impact of acute coronary syndrome on clinical, economic, and cardiac-specific health status after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: 1-year results from the stent or surgery (SoS) trial. Am. Heart J. 150(1), 175–181 (2005)CrossRef
10.
Taylor, M., Scuffham, P.A., McCollam, P.L., Newby, D.E.: Acute coronary syndromes in Europe: 1-year costs and outcomes. Curr. Med. Res. Opin. 23(3), 495–503 (2007)CrossRef
11.
Etemad, L.R., McCollam, P.L.: Total first-year costs of acute coronary syndrome in a managed care setting. J. Manag. Care Pharm. 11(4), 300–306 (2005)
12.
Giersiepen, M.P.H., Pohlabeln. H., Egidi, G., Pigeot I.: Die ICD-Kodierqualität für Diagnosen in der ambulanten Versorgung. Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz. 50, 1028–1038 (2007)
13.
German Institute for Medical Documentation (DIMDI): ICD-10-GM. Videel, Cologne (2003)
14.
15.
Federal Association of panel doctors (KBV): Einheitlicher Bewertungsmaßstab. Deutscher Ärzte-Verlag, Cologne (2001)
16.
Filler, G., Hermanns, P.M.: EBM2000plus. Ebner & Spiegel, Munich (2005)
17.
18.
Wittchen, H.-U., Glaesmer, H., März, W., et al.: Cardiovascular risk factors in primary care: methods and baseline prevalence rates—the DETECT program. Curr. Med. Res. Opin. 21(4), 619–629 (2005)CrossRef
19.
20.
BKK Bundesverband: Gesundheitsreport 2006, Demografischer und wirtschaftlicher Wandel—gesundheitliche Folgen. Essen (2006)
21.
Fricke, G., Günther, J., Zawinell, A.: ATC-Index mit DDD-Angaben für den deutschen Arzneimittelmarkt. WIdO, Bonn (2007)
22.
Dijksman, L.M., Hirsch, A., Winhausen, F., Asselman, F.F.: Cost effectiveness of early versus selectively invasive strategy in patients with acute coronary syndromes without ST-segment elevation. Int. J. Cardiol. 131(2), 204–211 (2009)CrossRef
23.
Epstein, D.M., Sculpher, M.J., Clayton, T.C., et al.: Costs of an early intervention versus a conservative strategy in acute coronary syndrome. Int. J. Cardiol. 127(2), 240–246 (2008)CrossRef
24.
Bramkamp, M., Radovanovic, D., Erne, P., Szucs, T.D.: Determinants of costs and the length of stay in acute coronary syndromes: a real life analysis of more than 10 000 patients. Cardiovasc. Drugs Ther. 21, 389–398 (2007)CrossRef
25.
Fricke, F.U., Silber, S.: Können Medikamente frei setzende Koronarstents eine Bypassoperation ersetzen? Herz 30(4), 332–338 (2005)CrossRef
26.
Bundesärztekammer (BÄK), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), Kassenärztliche Bundesvereinigung (KBV). Nationales Programm für Versorgungs-Leitlinien. Nationale Versorgungs-Leitlinie Chronische KHK. Kurzfassung, Version 1.8. http://​www.​khk.​versorgungsleitl​inien.​de (2008). Accessed 25 June 2009
27.
Metadata
Title
Expenditures of the German statutory health insurance system for patients suffering from acute coronary syndrome and treated with percutaneous coronary intervention
Authors
Heiko Friedel
Anne Delges
Johannes Clouth
Dana T. Trautvetter
Publication date
01-10-2010
Publisher
Springer-Verlag
Published in
The European Journal of Health Economics / Issue 5/2010
Print ISSN: 1618-7598
Electronic ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-009-0181-2

Other articles of this Issue 5/2010

The European Journal of Health Economics 5/2010 Go to the issue

Pricing and Reimbursement

Spanish recommendations on economic evaluation of health technologies

Original Paper

Health insurance for the poor: impact on catastrophic and out-of-pocket health expenditures in Mexico

Original Paper

Onset of disability and life satisfaction: evidence from the German Socio-Economic Panel

Original Paper

Health care utilisation and immigration in Spain

Original Paper

Use of formal and informal care services among older people in Ireland and France

Editorial

EJHE has an official impact factor of 1.337